Category

Cohort News

Liquet™ Medical Inc. Receives FDA 510(k) Clearance for the Versus™ Catheter: Hemodynamics-Led Thrombolysis (HLT) allows Physicians to Personalize the Treatment of Blood Clots in the Lungs utilizing Real-Time Pulmonary Artery Pressure.

//
Categories
Liquet Medical Inc., a pioneering medical device company committed to advancing patient care through innovative technologies, today announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its Versus™ Catheter. This innovative medical device is...
Read More →

NVIDIA acquires VinBrain

//
Categories
Chief executive officer of American technology giant NVIDIA Jensen Huang said the company has acquired VinBrain, a start-up under Vingroup that offers medical products that use artificial intelligence (AI). The acquisition took place after NVIDIA signed an agreement with the...
Read More →

Demonstrating commitment to continuous portfolio innovation, Centerline Biomedical receives FDA 510(k) clearance for new IOPS® Guidewire Handle and launches its latest software advancements

//
Categories
CLEVELAND, Dec. 4, 2024 /PRNewswire/ — Centerline Biomedical, Inc. (“Centerline”), an innovative leader in cardiovascular navigation and visualization systems, announced that the company has received US Food and Drug Administration (FDA) 510(k) clearance for its new IOPS Guidewire Handle. This...
Read More →

PhotoniCare Announces a First Close of $4.6 Million in Series B Financing, a Manufacturing Partnership with Gentex Corporation, and Relocation of its Headquarters to Grand Rapids, Michigan

//
Categories
GRAND RAPIDS, Mich., Dec. 03, 2024 (GLOBE NEWSWIRE) — PhotoniCare Inc., a medical device company dedicated to delivering innovation to frontline care that demonstrably enhances patient outcomes, is pleased to announce that it has secured $4.6 million in Series B...
Read More →

Forbes 30 Under 30 featuring StrokeDx

//
Categories
There are two different primary types of strokes. Diagnosing the correct one is crucial-but can take hours. Ballatori’s and Shahrestani’s company, StrokeDx has developed portable imaging devices that determine stroke type in minutes. Read More

Cancer Fund Impact Investments

//
Categories
CANCER FUND is pleased to announce its investment in NXgenPort, an early-stage company developing technology to advance remote monitoring of cancer patients’ health. This marks Cancer Fund I’s seventh investment and reflects its dedication to fostering impactful innovations in oncology....
Read More →